Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto, Japan.
Center for Development of Advanced Medical Technology; Jichi Medical University; Tochigi, Japan.
Organogenesis. 2013 Oct 1;9(4):235-8. doi: 10.4161/org.25760. Epub 2013 Jul 29.
Organ grafts developed in the xenogeneic pig scaffold are expected to resolve most issues of donor safety and ethical concerns about living-donor liver transplantation in Japan. We have been working on so-called "Yamaton" projects to develop transplantable organs using genetically engineered pigs. Our goal is to produce chimeric livers with human parenchyma in such pigs. The Yamaton-Liver project demonstrated the proof of concept by showing that rat-mouse chimeric livers could develop in mice and be successfully transplanted into syngeneic or allogeneic rats. Under conventional immunosuppression, the transplanted livers showed long-term function and protection against rejection. Because chimeric liver grafts have xenogeneic components, additional strategies, such as humanization of pig genes, induction of hematopoietic chimeras in donors, and replacement of pig endothelial cells with human ones, might be required in clinical use. Our projects still need to overcome various hurdles but can bring huge benefits to patients in the future.
在异种猪支架上开发的器官移植物有望解决日本供体安全和活体供肝移植的伦理问题。我们一直在进行所谓的“大和”项目,使用基因工程猪开发可移植的器官。我们的目标是在这些猪中产生具有人类实质的嵌合肝脏。Yamaton-Liver 项目通过证明鼠-鼠嵌合肝脏可以在小鼠中发育并成功移植到同基因或同种异体大鼠中,证明了概念验证。在常规免疫抑制下,移植的肝脏表现出长期功能并能防止排斥。由于嵌合肝移植物具有异种成分,因此在临床应用中可能需要额外的策略,例如猪基因的人源化、供体造血嵌合体的诱导以及用人类内皮细胞替代猪内皮细胞。我们的项目仍需要克服各种障碍,但将来可以为患者带来巨大的益处。